Skip to main content

Table 1 Analysis of the association between the expression level of p-S6 and clinicopathological features of NSCLC (n = 350)

From: Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer

Clinicopathological features (n) p-S6
N High (%) Low (%) P-value
Age (years)
  ≤ 50 95 48 (50.5) 47 (49.5)  
 >50 255 121 (47.5) 134 (52.5) 0.632
Gender
 Male 266 114 (42.9) 152 (57.1)  
 Female 84 55 (65.5) 29 (34.5) 0.000a
Clinical stage
 Stage I-II 151 75 (49.7) 76 (50.3)  
 Stage III 199 93 (46.7) 106 (53.3) 0.519
LN status
 LNM 210 117 (55.7) 93 (44.3)  
 No LNM 140 52 (37.1) 88 (62.9) 0.001a
Histological type
 SCC 154 47 (30.5) 107 (69.5)  
 ADC 196 122 (62.2) 74 (37.8) 0.000a
Pathological grade
 Well/ Moderate 152 77 (50.7) 75 (49.3)  
 Poor 198 92 (46.5) 106 (53.5) 0.452
Survival status
 Alive 187 77 (41.2) 110 (58.8)  
 Dead 163 92 (56.4) 71 (43.6) 0.005a
  1. aChi-square test, statistically significant difference (P < 0.05). Abbreviations: ADC Adenocarcinoma, SCC squamous cell carcinoma, LNM Lymph node metastasis